600873 梅花生物
交易中 03-03 13:14:14
资讯
新帖
简况
每周股票复盘：梅花生物（600873）推6279万份员工持股计划
证券之星 · 02-08
每周股票复盘：梅花生物（600873）推6279万份员工持股计划
梅花生物（600873）披露以集中竞价交易方式回购股份的回购报告书，2月4日股价上涨0.56%
证券之星 · 02-04
梅花生物（600873）披露以集中竞价交易方式回购股份的回购报告书，2月4日股价上涨0.56%
每周股票复盘：梅花生物（600873）董事高管拟增持3亿至3.5亿元
证券之星 · 01-18
每周股票复盘：梅花生物（600873）董事高管拟增持3亿至3.5亿元
梅花生物：公司年报中有关于税收政策的详细介绍
证券日报网 · 01-15
梅花生物：公司年报中有关于税收政策的详细介绍
1月14日增减持汇总：梅花生物等2股增持 航天发展等18股减持（表）
新浪证券 · 01-14
1月14日增减持汇总：梅花生物等2股增持 航天发展等18股减持（表）
梅花生物76名高管拟12个月内增持3.038亿至3.502亿元股份
美股速递 · 01-14
梅花生物76名高管拟12个月内增持3.038亿至3.502亿元股份
梅花生物最新公告：部分高管拟增持3亿元-3.5亿元公司股份
证券之星 · 01-14
梅花生物最新公告：部分高管拟增持3亿元-3.5亿元公司股份
梅花生物（600873）披露2021年员工持股计划股票出售完毕暨终止公告，1月5日股价上涨0.59%
证券之星 · 01-05
梅花生物（600873）披露2021年员工持股计划股票出售完毕暨终止公告，1月5日股价上涨0.59%
每周股票复盘：梅花生物（600873）推1.5亿员工持股计划
证券之星 · 01-02
每周股票复盘：梅花生物（600873）推1.5亿员工持股计划
梅花生物最新公告：拟以3500万元-5000万元回购股份
证券之星 · 2025-12-29
梅花生物最新公告：拟以3500万元-5000万元回购股份
梅花生物（600873）披露拟变更注册资本及取消监事会并修订《公司章程》，12月19日股价上涨0.1%
证券之星 · 2025-12-19
梅花生物（600873）披露拟变更注册资本及取消监事会并修订《公司章程》，12月19日股价上涨0.1%
梅花生物(600873.SH)拟推2026年员工持股计划
智通财经 · 2025-12-11
梅花生物(600873.SH)拟推2026年员工持股计划
每周股票复盘：梅花生物（600873）公司及子公司涉2.6亿元专利诉讼
证券之星 · 2025-11-23
每周股票复盘：梅花生物（600873）公司及子公司涉2.6亿元专利诉讼
梅花生物（600873）披露公司及子公司涉及诉讼的公告，11月21日股价下跌2.35%
证券之星 · 2025-11-21
梅花生物（600873）披露公司及子公司涉及诉讼的公告，11月21日股价下跌2.35%
梅花生物控股股东因证券市场操纵被判三年有期徒刑，缓刑五年
美股速递 · 2025-11-07
梅花生物控股股东因证券市场操纵被判三年有期徒刑，缓刑五年
每周股票复盘：梅花生物（600873）Q3净利增141.06%，股东户数增13.1%
证券之星 · 2025-11-02
每周股票复盘：梅花生物（600873）Q3净利增141.06%，股东户数增13.1%
梅花生物(600873)9月30日股东户数6.67万户，较上期增加13.1%
证券之星 · 2025-10-30
梅花生物(600873)9月30日股东户数6.67万户，较上期增加13.1%
图解梅花生物三季报：第三季度单季净利润同比增长141.06%
证券之星 · 2025-10-29
图解梅花生物三季报：第三季度单季净利润同比增长141.06%
每周股票复盘：梅花生物（600873）收购确认非经常性收益约7.8亿元
证券之星 · 2025-10-26
每周股票复盘：梅花生物（600873）收购确认非经常性收益约7.8亿元
梅花生物（600873）披露跨境收购业务与资产的进展公告，10月23日股价上涨1.12%
证券之星 · 2025-10-23
梅花生物（600873）披露跨境收购业务与资产的进展公告，10月23日股价上涨1.12%
暂无数据
公司概况
公司名称：
梅花生物科技集团股份有限公司
所属行业：
食品制造业
上市日期：
1995-02-17
主营业务：
梅花生物科技集团股份有限公司的主营业务是氨基酸的规模化生产。公司的主要产品是动物营养氨基酸类产品、食品味觉性状优化产品、人类医用氨基酸类、石油级黄原胶、生物有机肥等。
发行价格：
3.50
{"stockData":{"symbol":"600873","market":"SH","secType":"STK","nameCN":"梅花生物","latestPrice":11.4,"timestamp":1772514854000,"preClose":11.45,"halted":0,"volume":21591676,"delay":0,"changeRate":-0.0044,"floatShares":2804000000,"shares":2804000000,"eps":1.3445,"marketStatus":"交易中","change":-0.05,"latestTime":"03-03 13:14:14","open":11.46,"high":11.55,"low":11.24,"amount":245000000,"amplitude":0.0271,"askPrice":11.41,"askSize":160,"bidPrice":11.4,"bidSize":108,"shortable":0,"etf":0,"ttmEps":1.3445,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772521200000},"marketStatusCode":2,"adr":0,"adjPreClose":11.45,"symbolType":"stock","openAndCloseTimeList":[[1772501400000,1772508600000],[1772514000000,1772521200000]],"highLimit":12.6,"lowLimit":10.31,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2804241650,"isCdr":false,"pbRate":1.99,"roa":"--","peRate":8.478988,"roe":"19.73%","epsLYR":0.94,"committee":0.190204,"marketValue":31968000000,"turnoverRate":0.0077,"status":1,"floatMarketCap":31968000000},"requestUrl":"/m/hq/s/600873/tweets","defaultTab":"tweets","newsList":[{"id":"2609237675","title":"每周股票复盘：梅花生物（600873）推6279万份员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2609237675","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609237675?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:31","pubTimestamp":1770485470,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：梅花生物2026年员工持股计划已完成资金缴纳，参与对象共192人，认购份额为62,790,000份。公司公告汇总梅花生物关于2026年员工持股计划实施进展的公告梅花生物科技集团股份有限公司于2025年12月11日和12月29日分别召开第十届董事会第二十三次会议和2025年第二次临时股东大会，审议通过了公司2026年员工持股计划相关议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0188","BK0033","BK0070","BK0226","600873"],"gpt_icon":0},{"id":"2608052360","title":"梅花生物（600873）披露以集中竞价交易方式回购股份的回购报告书，2月4日股价上涨0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608052360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608052360?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:19","pubTimestamp":1770214754,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，梅花生物报收于10.72元，较前一交易日上涨0.56%，最新总市值为300.61亿元。该股当日开盘10.66元，最高10.79元，最低10.6元，成交额达2.74亿元，换手率为0.91%。近日，梅花生物披露《关于以集中竞价交易方式回购股份的回购报告书》。回购期限为董事会审议通过之日起不超过12个月。若未能在36个月内使用完毕，未使用部分将注销。公司董事长王爱军提议本次回购，并承诺未来3个月至6个月内无减持计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400041438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873","BK0033","BK0012","BK0070","BK0188","BK0226","BK0028"],"gpt_icon":0},{"id":"2604923285","title":"每周股票复盘：梅花生物（600873）董事高管拟增持3亿至3.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923285","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923285?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:07","pubTimestamp":1768676829,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，梅花生物报收于10.37元，较上周的10.21元上涨1.57%。本周，梅花生物1月15日盘中最高价报10.59元。梅花生物当前最新总市值290.8亿元，在化学制品板块市值排名12/170，在两市A股市值排名733/5183。增持价格将根据市场情况确定，不设价格上限。增持主体承诺在增持期间及增持完成后24个月内不减持所持股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0033","BK0188","600873","BK0226","BK0012","BK0028"],"gpt_icon":0},{"id":"2603985310","title":"梅花生物：公司年报中有关于税收政策的详细介绍","url":"https://stock-news.laohu8.com/highlight/detail?id=2603985310","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603985310?lang=zh_cn&edition=full","pubTime":"2026-01-15 21:18","pubTimestamp":1768483080,"startTime":"0","endTime":"0","summary":"证券日报网讯 1月15日，梅花生物在互动平台回答投资者提问时表示，公司年报中有关于税收政策的详细介绍；氨基酸相关产品依据国家税法规定享受出口退税政策。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180777.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0028","600873","BK0033","BK0226","BK0070","BK0012"],"gpt_icon":0},{"id":"2603561170","title":"1月14日增减持汇总：梅花生物等2股增持 航天发展等18股减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2603561170","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603561170?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:01","pubTimestamp":1768399260,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，1月14日，盘后梅花生物、光庭信息披露增持情况。包括航天发展、财达证券、光庭信息、安恒信息、吉大正元、青木科技、德美化工、朗威股份、中国西电、百傲化学、华人健康、恒光股份、普蕊斯、三柏硕、凯淳股份、恒工精密、哈焊华通、立高食品在内的18家A股上市公司披露减持情况。\n\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-14/doc-inhhhxnr6957756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0037","BK0226","BK0024","BK0012","BK0033","BK0214","BK0188","000547","BK0028","600873","BK0070"],"gpt_icon":0},{"id":"1180155154","title":"梅花生物76名高管拟12个月内增持3.038亿至3.502亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1180155154","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180155154?lang=zh_cn&edition=full","pubTime":"2026-01-14 21:03","pubTimestamp":1768395792,"startTime":"0","endTime":"0","summary":"梅花生物宣布，公司76名高级管理人员计划在未来12个月内，通过二级市场集中竞价交易方式增持公司股份，拟增持总金额介于3.038亿元至3.502亿元之间。此次增持计划彰显管理层对公司长期发展前景的信心，以及对公司内在价值的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0226","BK0028","BK0012","600873","BK0033","BK0188","BK0070"],"gpt_icon":0},{"id":"2603433616","title":"梅花生物最新公告：部分高管拟增持3亿元-3.5亿元公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2603433616","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603433616?lang=zh_cn&edition=full","pubTime":"2026-01-14 20:59","pubTimestamp":1768395595,"startTime":"0","endTime":"0","summary":"梅花生物公告称，公司部分董事、高级管理人员及其他核心管理层共计76名成员计划自2026年1月14日起最长不超过12个月内，通过二级市场购买的方式增持公司股份，拟合计增持股份的金额不低于30,375万元，不高于35,015万元。参与本次增持计划的增持主体均已书面承诺在增持计划实施期间不减持持有的公司股份，以及在增持计划全部实施完毕并由公司依法公告后24个月内，不通过任何方式减持本次增持所获得的公司股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400039528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0012","BK0070","600873","BK0028","BK0188","BK0226"],"gpt_icon":0},{"id":"2601002000","title":"梅花生物（600873）披露2021年员工持股计划股票出售完毕暨终止公告，1月5日股价上涨0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601002000","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601002000?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:47","pubTimestamp":1767606443,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，梅花生物报收于10.19元，较前一交易日上涨0.59%，最新总市值为285.75亿元。公司近日发布公告称，梅花生物科技集团股份有限公司2021年员工持股计划所持有的公司股票已通过集中竞价交易方式全部出售完毕，资产均为货币性资产，占公司目前总股本的1.78%。该员工持股计划存续期原为36个月，已于2024年2月11日届满，后经股东大会批准延长至2027年2月11日。根据相关规定，持股计划可提前终止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500026153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0188","BK0012","BK0070","BK0033","BK0028","600873"],"gpt_icon":0},{"id":"2600351840","title":"每周股票复盘：梅花生物（600873）推1.5亿员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2600351840","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600351840?lang=zh_cn&edition=full","pubTime":"2026-01-02 01:54","pubTimestamp":1767290050,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，梅花生物报收于10.26元，较上周的10.09元上涨1.68%。本周关注点公司公告汇总：梅花生物发布2026年员工持股计划，资金总额上限1.5亿元。公司公告汇总梅花生物发布2026年员工持股计划，参与对象为董事、监事、高管及核心骨干，总人数不超过300人，其中董监高9人。根据规定，持股计划可提前终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000401.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873","BK0033","BK0012","BK0070","BK0188","BK0226","BK0028"],"gpt_icon":0},{"id":"2595436782","title":"梅花生物最新公告：拟以3500万元-5000万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2595436782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595436782?lang=zh_cn&edition=full","pubTime":"2025-12-29 19:39","pubTimestamp":1767008391,"startTime":"0","endTime":"0","summary":"梅花生物(600873.SH)公告称，公司拟以集中竞价方式回购股份，回购资金总额不低于3500万元人民币（含），不高于5000万元人民币（含），资金来源为自有资金。回购股份将用于后续实施员工持股计划或股权激励，如未能在回购实施完成之后36个月内使用完毕已回购股份，尚未使用的已回购股份将予以注销。回购股份价格不超过15元/股，回购期限自董事会审议通过之日起不超过12个月。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900031349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","600873","BK0012","BK0028","BK0188","BK0070","BK0033"],"gpt_icon":0},{"id":"2592984991","title":"梅花生物（600873）披露拟变更注册资本及取消监事会并修订《公司章程》，12月19日股价上涨0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592984991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592984991?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:40","pubTimestamp":1766155256,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘，梅花生物报收于10.09元，较前一交易日上涨0.1%，最新总市值为282.95亿元。近日，梅花生物科技集团股份有限公司发布2025年第二次临时股东大会会议资料，公告显示公司拟召开2025年第二次临时股东大会，审议包括变更注册资本、取消监事会并修订《公司章程》、修订多项公司制度、实施2026年员工持股计划及相关管理办法，选举第十一届董事会非独立董事和独立董事，以及选聘容诚会计师事务所为2025年度审计机构等事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873","BK0070","BK0028","BK0226","BK0012","BK0188","BK0033"],"gpt_icon":0},{"id":"2590996635","title":"梅花生物(600873.SH)拟推2026年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2590996635","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590996635?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:14","pubTimestamp":1765444486,"startTime":"0","endTime":"0","summary":"智通财经APP讯，梅花生物(600873.SH)发布2026年员工持股计划(草案)，员工持股计划设立时计划份额合计不超过15,000万份，以“份”为认购单位，每1份额的认购价格为人民币1.00元，筹集资金总额上限为15,000万元。参加员工持股计划的总人数不超过300人，持股计划的存续期为60个月，自公司公告最后一笔标的股票过户至本员工持股计划名下之日起算。本员工持股计划所获标的股票自公司公告最后一笔标的股票过户至本员工持股计划名下之日起满12个月、24个月后分两期解锁，最长锁定期为24个月，每期解锁的标的股票比例分别为50%、50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0070","BK0226","600873","BK0028","BK0188","BK0033"],"gpt_icon":0},{"id":"2585410530","title":"每周股票复盘：梅花生物（600873）公司及子公司涉2.6亿元专利诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2585410530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585410530?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:25","pubTimestamp":1763839514,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，梅花生物报收于10.37元，较上周的11.0元下跌5.73%。本周，梅花生物11月17日盘中最高价报11.01元。本周关注点公司公告汇总：公司及子公司被诉侵犯专利权，涉案金额合计2.6亿元公司公告汇总梅花生物及全资子公司通辽梅花、新疆梅花、吉林梅花作为被告，收到广东省高级人民法院受理的两起诉讼案件。目前案件尚未开庭审理，公司表示将积极应诉，暂无法判断对公司损益的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873","BK0028","BK0226","BK0012","BK0188","BK0033","BK0070"],"gpt_icon":0},{"id":"2585141867","title":"梅花生物（600873）披露公司及子公司涉及诉讼的公告，11月21日股价下跌2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585141867?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:36","pubTimestamp":1763735805,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，梅花生物报收于10.37元，较前一交易日下跌2.35%，最新总市值为290.8亿元。该股当日开盘10.6元，最高10.67元，最低10.36元，成交额达4.08亿元，换手率为1.38%。近日，梅花生物发布关于公司及子公司涉及诉讼的公告。公告称，梅花生物及全资子公司通辽梅花、新疆梅花、吉林梅花作为被告，收到广东省高级人民法院受理的两起诉讼案件。目前案件尚未开庭审理，公司表示将积极应诉，暂无法判断对公司损益的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0028","BK0226","600873","BK0012","BK0033","BK0188"],"gpt_icon":0},{"id":"1157814185","title":"梅花生物控股股东因证券市场操纵被判三年有期徒刑，缓刑五年","url":"https://stock-news.laohu8.com/highlight/detail?id=1157814185","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157814185?lang=zh_cn&edition=full","pubTime":"2025-11-07 18:25","pubTimestamp":1762511115,"startTime":"0","endTime":"0","summary":"梅花生物控股股东因证券市场操纵被判三年有期徒刑，缓刑五年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0226","600873","BK0070","BK0012","BK0028","BK0033","BK0188"],"gpt_icon":0},{"id":"2580114472","title":"每周股票复盘：梅花生物（600873）Q3净利增141.06%，股东户数增13.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580114472","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580114472?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:50","pubTimestamp":1762037424,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，梅花生物报收于11.17元，较上周的10.81元上涨3.33%。股本股东变化股东户数变动截至2025年9月30日，公司股东户数为6.67万户，较6月30日增加7723.0户，增幅13.1%。其中第三季度主营收入59.35亿元，同比下降1.71%；单季度归母净利润12.57亿元，同比上升141.06%；单季度扣非净利润3.91亿元，同比下降16.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","600873","BK0012","BK0028","BK0188","BK0070","BK0033"],"gpt_icon":0},{"id":"2579719048","title":"梅花生物(600873)9月30日股东户数6.67万户，较上期增加13.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579719048","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579719048?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:17","pubTimestamp":1761815843,"startTime":"0","endTime":"0","summary":"户均持股数量由上期的4.84万股减少至4.21万股，户均持股市值为44.62万元。在化学制品行业个股中，梅花生物股东户数高于行业平均水平，截至9月30日，化学制品行业平均股东户数为2.8万户。从股价来看，2025年6月30日至2025年9月30日，梅花生物区间跌幅为0.75%，在此期间股东户数增加7723.0户，增幅为13.1%。根据统计，梅花生物2025年6月30日至2025年9月30日，主力资金净流出4.26亿元，游资资金净流出4508.98万元，散户资金净流入4.71亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000032193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0012","BK0033","BK0188","BK0028","600873","BK0070"],"gpt_icon":0},{"id":"2579031029","title":"图解梅花生物三季报：第三季度单季净利润同比增长141.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579031029","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579031029?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:15","pubTimestamp":1761740144,"startTime":"0","endTime":"0","summary":"证券之星消息，梅花生物2025年三季报显示，前三季度公司主营收入182.15亿元，同比下降2.49%；归母净利润30.25亿元，同比上升51.61%；扣非净利润20.19亿元，同比上升14.15%；其中2025年第三季度，公司单季度主营收入59.35亿元，同比下降1.71%；单季度归母净利润12.57亿元，同比上升141.06%；单季度扣非净利润3.91亿元，同比下降16.11%；负债率38.0%，投资收益4204.93万元，财务费用-1395.44万元，毛利率21.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873"],"gpt_icon":0},{"id":"2578629504","title":"每周股票复盘：梅花生物（600873）收购确认非经常性收益约7.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578629504","media":"证券之星","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578629504?lang=zh_cn&edition=full","pubTime":"2025-10-26 02:26","pubTimestamp":1761416772,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，梅花生物报收于10.81元，较上周的10.82元下跌0.09%。本周，梅花生物10月24日盘中最高价报10.95元。截至2025年6月30日，标的资产评估值为162,570.59万元，采用资产基础法评估结果。本次交易完成后，标的资产纳入公司合并报表范围。根据企业会计准则，预计2025年度合并利润表将确认营业外收入约7.8亿元，属非经常性损益，最终数据以2025年年度报告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0033","BK0188","600873","BK0070","BK0226","BK0028"],"gpt_icon":0},{"id":"2577710003","title":"梅花生物（600873）披露跨境收购业务与资产的进展公告，10月23日股价上涨1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577710003","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577710003?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:18","pubTimestamp":1761211131,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，梅花生物报收于10.79元，较前一交易日上涨1.12%，最新总市值为302.58亿元。该股当日开盘10.72元，最高10.83元，最低10.65元，成交额达2.02亿元，换手率为0.67%。近日，梅花生物发布关于跨境收购业务与资产的进展公告。交易对价基于交割日标的资产现金留存及营运资本调整，约为168亿日元，最终对价以双方商定为准。截至2025年6月30日，标的资产评估值为162,570.59万元，采用资产基础法评估结果。本次交易完成后，标的资产纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300026704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0070","BK0226","BK0028","600873","BK0033","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772514859937,"stockEarnings":[{"period":"1week","weight":0.039},{"period":"1month","weight":0.04},{"period":"3month","weight":0.1214},{"period":"6month","weight":0.0602},{"period":"1year","weight":0.2855},{"period":"ytd","weight":0.1303}],"compareEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":0.0157},{"period":"3month","weight":0.0731},{"period":"6month","weight":0.0968},{"period":"1year","weight":0.2595},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"梅花生物科技集团股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"66675人(较上一季度增加13.10%)","perCapita":"42058股","listingDate":"1995-02-17","address":"西藏自治区拉萨市堆龙德庆区金珠西路158号阳光新城11幢5号","registeredCapital":"280424万元","survey":" 梅花生物科技集团股份有限公司的主营业务是氨基酸的规模化生产。公司的主要产品是动物营养氨基酸类产品、食品味觉性状优化产品、人类医用氨基酸类、石油级黄原胶、生物有机肥等。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"梅花生物(600873)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供梅花生物(600873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"梅花生物,600873,梅花生物股票,梅花生物股票老虎,梅花生物股票老虎国际,梅花生物行情,梅花生物股票行情,梅花生物股价,梅花生物股市,梅花生物股票价格,梅花生物股票交易,梅花生物股票购买,梅花生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"梅花生物(600873)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供梅花生物(600873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}